Korean J Nutr.  2003 Oct;36(8):828-833.

Diallyl Disulfide Enhances Daunorubicin-Induced Apoptosis of HL-60 Cells

Affiliations
  • 1Department of Biochemistry, School of Medicine, Chonbuk National University, Jeonju, Korea.
  • 2Department of Oral Biochemistry, School of Dentistry and Institute of Oral Bioscience, Chonbuk National University, Jeonju, Korea.
  • 3Department of Food and Nutrition, Chonbuk National University, Jeonju, Korea.
  • 4Department of Physiology, Wonkwang University, Iksan, Korea.

Abstract

Dially disulfide (DADS), a component of garlic (Allium sativum), has been known to exert potent chemopreventive activity against various cancers. In this study, the synergistic effect of DADS and daunorubicin on the cytotoxicity of HL-60 cells, a human leukemia cell line, was investigated. DADS at 25 M greatly potentiated daunorubicin-induced cell death, decreasing cell viabilityto50%ofthe control. Daunorubicin-induced apoptosis was accompanied by the activation of caspase-3, the degradation of poly-(ADP-ribose) polymerase (PARP) and D4-GDI, and DNA fragmentation, which were blocked by pre-treatment with acetyl-Asp-Glu-Val-Asp- dialdehyde (Ac-DEVD-CHO). Treatment that combined 25 M DADS and 100 nM daunorubicin caused a similar degree of caspase-3 activation, PARP and D4-GDI degradation, and DNA fragmentation to that caused by treatment with 250 nM daunorubicin alone. These results indicate that combined therapy using daunorubicin with DADS, a component of food, and garlic can effectively decrease the therapeutic dose of daunorubicin, preventing the severe side effects of daunorubicin.

Keyword

dially disulfide; daunorubicin; synergistic effect; apoptosis

MeSH Terms

Apoptosis*
Caspase 3
Cell Death
Cell Line
Daunorubicin
DNA Fragmentation
Garlic
HL-60 Cells*
Humans
Leukemia
Caspase 3
Daunorubicin
Full Text Links
  • KJN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr